Doxecitine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Doxecitine. Educational only — not medical advice.
Labeled uses
KYGEVVI is indicated for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom onset on or before 12 years.
Source: FDA labeling via NIH DailyMed (set 7d5ce670…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.